GSK Relocates R&D Center to Cambridge with Multi-Million Pound Investment

Pharmaceutical giant GSK is moving its research and development center to Cambridge, planning investments of nearly half a billion pounds in the university city, which is already home to AstraZeneca.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

fazGerman10d ago

GSK verlegt R&D-Zentrum: Hunderte Millionen für den Forschungsstandort Cambridge

Der Pharmakonzern GSK verlegt sein Forschungszentrum in die Universitätsstadt, wo schon AstraZeneca sitzt. Er plant Investitionen für fast eine halbe Milliarde Pfund.

Read full article →

PERSPECTA

PERSPECTA

GSK Relocates R&D Center to Cambridge with Multi-Million Pound Investment

Sources

GSK verlegt R&D-Zentrum: Hunderte Millionen für den Forschungsstandort Cambridge

Related Stories

Nigeria and China Deepen Agricultural Partnership

US Senate's Russia Sanctions Bill Faces Hurdles

Pagadian's 'Salt Sisters' Revive Traditional Salt Industry

After-Tax Portfolio Income Comparison: Florida vs. New York

PERSPECTA